4.6 Article

Graft Failure and Intraocular Pressure Control After Keratoplasty in Iridocorneal Endothelial Syndrome

期刊

AMERICAN JOURNAL OF OPHTHALMOLOGY
卷 160, 期 3, 页码 422-429

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajo.2015.05.024

关键词

-

资金

  1. National Research Foundation Translational Clinical Research grant
  2. Bausch & Lomb, Bridgewater, New Jersey
  3. NMRC
  4. Carl Zeiss Meditec, Oberkochen Germany
  5. Ziemer Ophthalmic Systems AG, Port, Switzerland

向作者/读者索取更多资源

PURPOSE: To describe and compare graft survival and intraocular pressure (IOP) control after penetrating keratoplasty (PK) and Descemet stripping automated endothelial keratoplasty (DSAEK) in eyes with iridocorneal endothelial (ICE) syndrome. DESIGN: Retrospective case series. METHODS: Multicenter study conducted at the Singapore National Eye Centre (SNEC) and Price Vision Group. Twenty-nine consecutive eyes with ICE syndrome that underwent keratoplasty between 1991 and 2011 were identified from the SNEC transplant database and Price Vision Group patient database and the following data extracted: demographics, graft failure, IOP indices, and glaucoma treatment pre- and postkeratoplasty. The main outcome measures were graft failure and need for additional IOP-lowering treatment after keratoplasty. RESULTS: The mean follow-up duration was 7.0 +/- 4.9 years in the PK group (n=17) and 4.0 +/- 2.6 years in the DSAEK group (n=12). After a mean of 4.1 +/- 3.1 years, 37.9% of grafts (11/29) failed: 7 PK compared to 4 DSAEK (P=.72). The graft failure rate was 50% in eyes with prekeratoplasty glaucoma surgery vs 31.6% in those without (P=.43). Additional glaucoma treatment was required in 37.9% of eyes (11/29): 41.2% of PK eyes and 50% of DSAEK eyes (P=.28) Eyes that had undergone glaucoma surgery before keratoplasty were less likely to require escalation of IOP-lowering therapy postkeratoplasty (9.1% vs 50%, P=.03). CONCLUSIONS: One-third of grafts failed after keratoplasty for ICE syndrome at a mean duration of 4 years and additional 'OP-lowering treatment was required in 37.9%. Both PK and DSAEK had similar outcomes with regard to graft failure and TOP control. (C) 2015 by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据